Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Fragmin approved in U.S. for treatment of unstable angina and non-Q wave MI

May 31, 1999

Avigen cleared to begin human trials of gene therapy product for hemophilia

May 26, 1999

Thrombin inhibitors developed by Merck scientists

May 13, 1999

Yamanouchi describes novel series of factor Xa inhibitors

May 10, 1999

Kissei develops new anticoagulants acting selectively against factor Xa

May 7, 1999

Glaxo Wellcome dicloses novel class of serine protease inhibitors

May 6, 1999

Antithrombotic agents synthesized and tested at Roche

May 5, 1999

Inhibitors of factor Xa recently disclosed by DuPont

May 3, 1999

Orally active fibrinogen antagonist developed by Merck

May 3, 1999

Potent and selective small-molecule thrombin inhibitor developed at DuPont

April 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...